Outset Medical, Inc. (OM)

Market Cap	27.41M
Revenue (ttm)	116.43M
Net Income (ttm)	-159.18M
Shares Out	52.09M
EPS (ttm)	-3.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	641,655
Open	0.520
Previous Close	0.530
Day's Range	0.509 - 0.535
52-Week Range	0.435 - 12.450
Beta	1.91
Analysts	Buy
Price Target	4.42 (+739.83%)
Earnings Date	Nov 5, 2024

About OM

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 15, 2020
• Employees: 480
• Stock Exchange: NASDAQ
• Ticker Symbol: OM
• Website: https://www.outsetmedical.com

Financial Performance

In 2023, Outset Medical's revenue was $130.38 million, an increase of 13.00% compared to the previous year's $115.38 million. Losses were -$172.80 million, 6.04% more than in 2022.

Analyst Forecast

According to 6 analysts, the average rating for OM stock is "Buy." The 12-month stock price forecast is $4.42, which is an increase of 739.83% from the latest price.

Price Target

$4.42

(739.83% upside)

Analyst Consensus: Buy